Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling
Naureen Fatima, Sanket Patel, Tahir Hussain
Hypertension (2021) Vol. 77, Iss. 6, pp. 1845-1856
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

The Angiotensin AT2Receptor: From a Binding Site to a Novel Therapeutic Target
U. Muscha Steckelings, Robert E. Widdop, Edward D. Sturrock, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 1051-1135
Open Access | Times Cited: 53
Angiotensin II: A novel biomarker in vascular diseases
Qinyi Zhou, Jing Pan, Wang Liu, et al.
Clinica Chimica Acta (2025) Vol. 568, pp. 120154-120154
Closed Access | Times Cited: 1
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 18
Renin Angiotensin Blockers and Cardiac Protection: From Basics to Clinical Trials
Bernard Lévy, Jean‐Jacques Mourad
American Journal of Hypertension (2021) Vol. 35, Iss. 4, pp. 293-302
Open Access | Times Cited: 31
The Pan-liver Network Theory
Yaxing Zhang, Xian-Ming Fang
The Chinese Journal of Physiology (2023) Vol. 66, Iss. 6, pp. 401-436
Open Access | Times Cited: 12
Renin angiotensin aldosterone system in pulmonary fibrosis: Pathogenesis to therapeutic possibilities
Dipankar Gupta, Ashok Kumar, Avinash Singh Mandloi, et al.
Pharmacological Research (2021) Vol. 174, pp. 105924-105924
Closed Access | Times Cited: 26
The Balance Between the Natriuretic Peptides and the Renin-Angiotensin-Aldosterone System in the Preservation of Ideal Cardiovascular Health
Speranza Rubattu, Giovanna Gallo, Massimo Volpe
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 626-626
Open Access
GPCR dimerization: Drug discovery aspects and targets in renin‐angiotensin systems
Tahmid Faisal, Tahir Hussain
FASEB BioAdvances (2025)
Open Access
Supplementation with the Postbiotic BPL1™-HT (Heat-Inactivated Bifidobacterium animalis subsp. Lactis) Attenuates the Cardiovascular Alterations Induced by Angiotensin II Infusion in Mice
Mario de la Fuente-Muñoz, Marta Román‐Carmena, Sara Amor, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 193-193
Open Access
Angiotensin-(1-7) protective effects in neurocognitive disorders: molecular mechanisms to therapeutic implications
Lillia Lucas, Katherine Kimbark, Victoria Vernail, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting
David Speck, Gunnar Kleinau, Michal Szczepek, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 16
Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics
Jian Yang, John E. Hall, Pedro A. José, et al.
Pharmacology & Therapeutics (2022) Vol. 239, pp. 108194-108194
Open Access | Times Cited: 13
Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice
Min-Chun Liao, Kana N. Miyata, Shiao‐Ying Chang, et al.
Clinical Science (2022) Vol. 136, Iss. 10, pp. 715-731
Open Access | Times Cited: 11
Angiotensin-(1–9) in hypertension
Ignacio Norambuena‐Soto, Camila López‐Crisosto, Javiera Martinez-Bilbao, et al.
Biochemical Pharmacology (2022) Vol. 203, pp. 115183-115183
Closed Access | Times Cited: 11
Computational investigation of the impact of potential AT 2 R polymorphism on small molecule binding
Bhanu Sharma, Md Tabish Rehman, Mohamed F. Alajmi, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 5, pp. 2231-2241
Closed Access | Times Cited: 6
The Renin-Angiotensin System as a Component of Biotrauma in Acute Respiratory Distress Syndrome
Katharina Krenn, Verena Tretter, Felix Kraft, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 10
Educational Review: The Impact of Perinatal Oxidative Stress on the Developing Kidney
Marissa J. DeFreitas, Chryso Katsoufis, Merline Benny, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 10
Microglial angiotensin type 2 receptors mediate sex‐specific expression of inflammatory cytokines independently of circulating estrogen
Pablo Garrido‐Gil, María A. Pedrosa, María García-Garrote, et al.
Glia (2022) Vol. 70, Iss. 12, pp. 2348-2360
Open Access | Times Cited: 10
2-phenylacetamide Separated from the seed of Lepidium apetalum Willd. inhibited renal fibrosis via MAPK pathway mediated RAAS and oxidative stress in SHR Rats
Peipei Yuan, Meng Li, Qi Zhang, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
G-protein-coupled receptor kinase 4 causes renal angiotensin II type 2 receptor dysfunction by increasing its phosphorylation
Fuwei Zhang, Lifu Lei, Juan Huang, et al.
Clinical Science (2022) Vol. 136, Iss. 12, pp. 989-1003
Open Access | Times Cited: 9
Endothelial Cell Plasma Membrane Biomechanics Mediates Effects of Pro-Inflammatory Factors on Endothelial Mechanosensors: Vicious Circle Formation in Atherogenic Inflammation
Nadezhda Barvitenko, Mohammad Ashrafuzzaman, Alfons Lawen, et al.
Membranes (2022) Vol. 12, Iss. 2, pp. 205-205
Open Access | Times Cited: 8
Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19
Abdisa Tufa, Tewodros Haile Gebremariam, Tsegahun Manyazewal, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0275391-e0275391
Open Access | Times Cited: 8
Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes
Anthony Belenchia, Asma Boukhalfa, Vincent G. DeMarco, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1373-1373
Open Access | Times Cited: 4
Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance
Krzysztof Mińczuk, Marta Baranowska‐Kuczko, Anna Krzyżewska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6350-6350
Open Access | Times Cited: 7
Strategies to address diabetic kidney disease burden in Mexico: a narrative review by the Mexican College of Nephrologists
Silvia Palomo‐Piñón, Jesús Armando Aguilar-Alonso, Jonathan S. Chávez-Íñiguez, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top